Mody, Kabir http://orcid.org/0000-0003-3254-2990
Mansfield, Aaron S.
Vemireddy, Lalitha
Nygren, Peter
Gulbo, Joachim
Borad, Mitesh
Article History
Received: 16 October 2018
Accepted: 15 November 2018
First Online: 21 November 2018
Compliance with ethical standards
:
: <b>Kabir Mody</b>:<i>Research Support</i>) Senwha Biociences Inc., Tracon Pharmaceuticals, Genentech; Astrazeneca/Medimmune; Arqule, Inc.; Agios; Taiho Oncology; Boston Biomedical; Ipsen.<i>Consulting/Advisory Board</i>) Eisai Co, Ltd., Bayer Pharmaceuticals.<b>Mitesh Borad</b>:<i>Research Support</i>) Boston Biomedical, miRNA Therapeutics, Senwha Biociences Inc., Astrazeneca/Medimmune, BiolineRx, Agios, Halozyme, Celgene, Threshold Pharmaceuticals, Toray Industries, Dicerna, Sillajen, Eisai, Taiho Pharmaceuticals, EMD Serono, Isis Pharmaceuticals, Incyte, Sun Biopharma, Ariad, ImClone Systems, QED Therapeutics.<i>Consulting/Advisory Board</i>) G1 Therapeutics, TD2, Fujifilm, Agios, Insys Therapeutics, Novartis, ArQule, Celgene, Inspyr Therapeutics, Halozyme, Pieris Pharmaceuticals, Taiho Pharmaceuticals.Stock and Other Ownership Interests) GlaxoSmithKline, Gilead Sciences, AVEO.<i>Travel, Accomodations, Expenses</i>) ArQule, Celgene, Astrazeneca.<b>Aaron Mansfield</b>:<i>Research Support</i>) NIH, Novartis and Verily.<i>Consulting/Advisory Board</i>) Honoraria are paid to institution for participation in advisory boards for Abbvie, BMS and Genentech.<b>Peter Nygren</b>: shareholder in Vivolux AB.<b>Joachim Gulbo</b>: shareholder in and consultant to Vivolux AB.All other authors have no relevant conflicts of interest to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.